Peapod Lane Capital’s iTeos Therapeutics ITOS Stock Holding History

Peapod Lane Capital’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-169,287	Closed	-$1.69M	–	59
2025 Q2	$1.69M	Buy	169,287 +33,632	+25%	+$271K	1.69%	25
2025 Q1	$810K	Buy	135,655 +26,802	+25%	+$197K	0.91%	40
2024 Q4	$836K	Buy	+108,853	New	+$935K	0.83%	46

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Peapod Lane Capital's ITOS Position: Q3 2025 in Review

Peapod Lane Capital sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 169,287 shares — an estimated $1.69M sold.

Peapod Lane Capital first reported a position in ITOS in Q4 2024 and held it in 3 quarters. The position peaked at $1.69M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Peapod Lane Capital reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Peapod Lane Capital sold 169,287 iTeos Therapeutics shares in Q3 2025, an estimated $1.69M.
Peapod Lane Capital first reported a position in iTeos Therapeutics in Q4 2024 and held it in 3 quarters.
Peapod Lane Capital's iTeos Therapeutics position peaked at $1.69M in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Peapod Lane Capital's 13F filing for Q3 2025, filed 10 Nov 2025.